Literature DB >> 23794602

Characterization of a major facilitator superfamily (MFS) tripartite efflux pump EmrCABsm from Stenotrophomonas maltophilia.

Yi-Wei Huang1, Rouh-Mei Hu, Fang-Yeh Chu, Hui-Rung Lin, Tsuey-Ching Yang.   

Abstract

OBJECTIVES: To characterize the emrRCABsm operon of Stenotrophomonas maltophilia.
METHODS: The presence of the emrRCABsm operon was verified by RT-PCR. The regulatory role of EmrRsm was investigated by ΔemrRsm mutant construction and promoter transcriptional fusion assay. A susceptibility test was employed to assess the substrate spectrum of the EmrCABsm efflux pump. The requirement for each component of the EmrCABsm pump was assessed by individual mutant construction and susceptibility testing. The expression of the emrRCABsm operon was evaluated by an induction assay, using different compounds as inducers.
RESULTS: emrRsm, emrCsm, emrAsm and emrBsm formed a four-member operon that was negatively regulated by the MarR-type transcriptional regulator EmrRsm. The emrRCABsm operon was intrinsically poorly expressed and the EmrCAB pump favoured extrusion of the uncoupling agents carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and tetrachlorosalicylanilide (TCS), and the hydrophobic antibiotics nalidixic acid and erythromycin. However, the emrRCABsm operon could not be derepressed by CCCP, nalidixic acid, TCS, 2-chlorophenylhydrazine hydrochloride or salicylate, which are known to be possible inducers for MarR-type regulons. Each component of the EmrCABsm pump was apparently essential for pump function.
CONCLUSIONS: The EmrRsm-regulated EmrCABsm efflux pump is involved in the extrusion of hydrophobic compounds.

Entities:  

Keywords:  antibiotic resistance; bacteria; efflux pump

Mesh:

Substances:

Year:  2013        PMID: 23794602     DOI: 10.1093/jac/dkt250

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  20 in total

Review 1.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 2.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

3.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

4.  Roles of SmeYZ, SbiAB, and SmeDEF Efflux Systems in Iron Homeostasis of Stenotrophomonas maltophilia.

Authors:  Chao-Jung Wu; Yu Chen; Li-Hua Li; Cheng-Mu Wu; Yi-Tsung Lin; Cheng-Hua Ma; Tsuey-Ching Yang
Journal:  Microbiol Spectr       Date:  2022-06-01

Review 5.  Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung.

Authors:  Quentin Menetrey; Pauline Sorlin; Estelle Jumas-Bilak; Raphaël Chiron; Chloé Dupont; Hélène Marchandin
Journal:  Genes (Basel)       Date:  2021-04-21       Impact factor: 4.096

Review 6.  Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia.

Authors:  María B Sánchez
Journal:  Front Microbiol       Date:  2015-06-30       Impact factor: 5.640

Review 7.  The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia.

Authors:  Jaclyn G McCutcheon; Jonathan J Dennis
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

8.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

Review 9.  Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.

Authors:  Ya-Ting Chang; Chun-Yu Lin; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2015-09-02       Impact factor: 5.640

10.  Structure of the periplasmic adaptor protein from a major facilitator superfamily (MFS) multidrug efflux pump.

Authors:  Philip Hinchliffe; Nicholas P Greene; Neil G Paterson; Allister Crow; Colin Hughes; Vassilis Koronakis
Journal:  FEBS Lett       Date:  2014-07-01       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.